Page 870 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 870

Gastrointestinal system: 4.2 The lower gastrointestinal tr act                  845



  VetBooks.ir  4.167                                     4.168




















          Fig. 4.167  Mucosal surface of the large colon from a   Fig. 4.168  Magnified view of cyathostome larvae in
          foal with severe cyathostominosis. Note the numerous   the intestinal wall.
          small larvae in the mucosal wall.


            Table 4.11  Anthelmintic treatment options for cyathostominosis

           DRUG            DOSE             FREQUENCY         COMMENTS
           Ivermectin      0.2 mg mg/kg p/o  Once             Effective against adults
           Moxidectin      0.4 mg/kg p/o    Once              Effective against adults and encysted larvae
           Fenbendazole    50 mg/kg p/o     Once              Effective against adults; resistance is a concern
                           10 mg/kg p/o     q24 h for 5 days
           Oxfendazole     10 mg/kg p/o     Once              Effective against adults; resistance is a concern
           Pyrantel tartrate  2.2 mg/kg p/o  Daily            Effective against ingested larvae; resistance is a concern


            Definitive diagnosis is often achieved at necropsy,   less inflammatory response than fenbendazole and
          where oedema and thickening of the intestinal wall   resistance is less of a concern. Other regimes include
          are evident. Encysted cyathostomes may be evident   administration of fenbendazole (10 mg/kg) on days
          grossly in the intestinal mucosa (Figs. 4.167, 4.168).  1–5, 16–20 and 31–35, with ivermectin on days 6,
                                                         21  and 36)  may  be useful. Another recommends a
          Management                                     single course of fenbendazole (10 mg/kg p/o q24h
          There are two aspects of management: treatment   for 5 days) (Table 4.11). Concurrent administration
          of horses with overt enteric disease (diarrhoea   of anti-inflammatories such as corticosteroids may
          and/or  hypoproteinaemia),  and  reduction  of  para-  also be useful because of the inflammatory response
          site burdens. Treatment of horses with diarrhoea   associated with the emergence or death of larvae (e.g.
          and/or hypoproteinaemia is largely supportive in   prednisolone, 1 mg/kg p/o q24 h).
          nature. Correction of fluid and electrolyte imbal-  The diagnosis and management of  cyathos-
          ances is important, and intravenous fluid therapy is   tominosis are difficult and therefore routine preven-
          often required. Plasma or synthetic colloids may be   tive control is critical. Few drugs are effective against
          required in severely hypoproteinaemic animals.  encysted larvae. As for any intestinal parasite, opti-
            Different treatment regimes have been proposed   mal deworming programmes vary between farms
          to reduce the parasite burden. Moxidectin (0.4 mg/  based on a variety of factors. The period of highest
          kg p/o once) has good efficacy against encysted larvae   risk for infection should be considered when design-
          and is considered the treatment of choice as it elicits   ing a deworming programme. Horses are more
   865   866   867   868   869   870   871   872   873   874   875